Skip to content

Company information lookup

ONCOSIL MEDICAL LTD (OSL)

Oncology Research and Development

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
OSL 0.115 0% 0.110 0.115 0.000 0.000 0.000 0

ONCOSIL MEDICAL LTD details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code OSL
Securities
Official Listing Date 15 August, 2005
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.oncosil.com.au
Registered Office Address Suite 7, Level 8, Goldfields House, 1 Alfred Street, SYDNEY, NSW, AUSTRALIA, 2000
Head Office Telephone (02) 9223 3344
Head Office Fax (02) 9221 8535
Share Registry SECURITY TRANSFER REGISTRARS PTY. LIMITED
770 CANNING HIGHWAY, APPLECROSS, WA, AUSTRALIA, 6153
Share Registry Telephone (08) 9315 2333
Directors / Senior Management
Mr Martin Rogers (Chairman, Non Exec. Director)
Dr Roger Aston (Executive Chairman, Non Exec. Director)
Dr Neil Frazer (CEO, Executive Director)
Mr Lawrence Gozlan (Non Exec. Director)
Mr Nicholas Falzon (CFO)
Company Secretary Mr Peter Casey (Joint Co. Secretary)
Mr Nicholas Falzon (Joint Co. Secretary)
Principal Activities Oncology Research and Development

ONCOSIL MEDICAL LTD announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
09/09/2014 asterix Board and senior management restructure 3 PDF
29/08/2014 asterix Appendix 4E 64 PDF
31/07/2014 asterix Appendix 4C - quarterly 6 PDF
18/07/2014   Bioshares investor conference 2014 presentation 18 PDF
17/07/2014   Investor Update July 2014 5 PDF
16/07/2014 asterix GMP manufacturing process finalised for OncoSil Medical 3 PDF
15/07/2014 asterix Ethics Approval Granted for OncoSil in Pancreatic Cancer 3 PDF
26/05/2014   Appendix 3B 13 PDF
08/05/2014   Investor update 22 PDF
29/04/2014   Results of Meeting 2 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
30 Sep 2014 0.115 9.52% 0.115 0.105 760,951
29 Sep 2014 0.105 -12.5% 0.115 0.105 602,541
26 Sep 2014 0.120 0% 0.125 0.115 899,139
25 Sep 2014 0.120 0% 0.125 0.120 189,000
24 Sep 2014 0.120 -7.69% 0.130 0.120 76,834

* Volume of shares shown represents only those shares traded on ASX.

ONCOSIL MEDICAL LTD price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security OSL. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security OSL

Warrants & Structured Products

No warrants & Structured Products are available over the security OSL